<?xml version="1.0" encoding="UTF-8"?>
<p>Until now the number of COVID-19 patients with known outcomes of convalescent plasma administration is particularly limited, stemming from 6 case series.
 <sup>
  <xref rid="R20" ref-type="bibr">20</xref>â€“
  <xref rid="R26" ref-type="bibr">26</xref>
 </sup> The follow-up of cases reaching hospitalizations of 51 days
 <sup>
  <xref rid="R21" ref-type="bibr">21</xref>
 </sup> and 60 days after onset of symptoms
 <sup>
  <xref rid="R23" ref-type="bibr">23</xref>
 </sup> highlights the need for adequate observation, but also underlines the time needed from the early, sizable Chinese cohorts (reportedly reaching 245 COVID-19 patients, with improvement in 91 of them)
 <sup>
  <xref rid="R51" ref-type="bibr">51</xref>
 </sup> to provide robust results in relevant scientific publications.
</p>
